On Friday, Cognition Therapeutics Inc (CGTX) stock saw a modest uptick, ending the day at $0.63 which represents no change from the prior close of of $0.63. The stock opened at $0.64 and touched a low ...

Researchers at the California Institute of Technology have unveiled a startling revelation about the human mind: our thoughts ...

Language and social cognition are fundamental to human communication. But how do these capacities interact? In a review paper ...

the research team developed a preclinical model of human brain stimulation therapy and found that this therapy works by ...

AI isn't just changing how we think—it's dissolving the boundaries between human and machine cognition in unexpected ways.

Cognition Therapeutics (CGTX) announced topline results from the exploratory Phase 2 ‘SHIMMER’ study demonstrating CT1812 ...

Cognition Therapeutics' CT1812 improves dementia with Lewy bodies outcomes, reducing anxiety, hallucinations, and functional ...

This second route to joy is demonstrated in the prayer of another Old Testament prophet, Habakkuk. In response to his ...

Writing skills are going to become very critical because people are going to be able to tell the difference between AI ...

Higher frequency of antibiotic use was not associated with dementia or cognitive impairment; neither was long-term use. No ...